DOCSLIB.ORG

Understanding Mania in Bipolar Disorder: Perspectives on Causation and Pathogenesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Understanding Mania in Bipolar Disorder: Perspectives on Causation and Pathogenesis Understanding mania in bipolar disorder: perspectives on causation and pathogenesis Emmanuelle Charlotte Sophie Bostock Bachelor of Psychology (Hons) University of Tasmania Graduate Certificate in Evidence-Based Complementary Medicine University of Tasmania Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Psychology, School of Medicine University of Tasmania July 2018 i Table of Contents Declaration of originality iv Statement of authority of access iv Statement regarding published work contained in thesis iv Copyright permission to reproduce published materials v Acknowledgements vi Statement of co-authorship vii List of figures ix List of tables x Abbreviations xi Abstract 1 Chapter 1: Introduction and Thesis Overview 3 1.1.1 An overview of mania 4 1.1.2 Diagnosis of mania and bipolar disorder 6 1.1.3 Prevalence, incidence and course of bipolar disorder 11 1.1.4 Aetiological factors in bipolar disorder 14 1.1.5 Pathophysiology of mania 16 1.1.6 Findings from brain activation and brain imaging 19 1.1.7 Comparison of bipolar disorder with reference conditions 21 1.2 Mania and temporal lobe epilepsy 22 1.2.1 Temporal lobe epilepsy and seizures 23 1.2.2 Similarities between bipolar disorder and epilepsy 24 1.2.3 Treatment overlaps between bipolar disorder and epilepsy 25 ii 1.2.4 Prevalence ratio of BD in epilepsy 26 1.3 Research publications investigating similarities between mania and TLE 27 1.3.1 Precipitating factors 27 1.3.2 Neuropsychological deficits 28 1.3.3 The Ketogenic Diet 28 1.3.4 Herbal Medicine Associated Mania 30 Chapter 2 : Comparison of precipitating factors for mania and partial 27 seizures: Indicative of shared pathophysiology Introduction 32 Methods 33 Results 33 Discussion 36 References 38 Chapter 3: Systematic review of cognitive function in euthymic bipolar 42 disorder and pre-surgical temporal lobe epilepsy Introduction 44 Method 44 Identification of studies 45 Data extraction 45 Results 45 Discussion 47 References 52 Chapter 4: The current status of the ketogenic diet in psychiatry 56 Introduction 58 Method 59 Results 59 iii Discussion 62 References 64 Chapter 5: Mania associated with herbal medicines, other than cannabis: a 67 systematic review and quality assessment of case reports Introduction 69 Method 70 Results 70 Discussion 72 References 75 Chapter 6: General Discussion 82 6.1 Summary of results 83 6.1.1 Precipitating factors for mania and partial seizures 83 6.1.2 Neurocognition 85 6.1.3 The ketogenic diet 85 6.1.4 Mania associated with herbal medicine 86 6.2 Limitations 87 6.2.1 Review methodologies: Narrative review and systematic review 87 6.2.2 Comparison with a reference condition 88 6.2.3 Limitations of the individual studies 89 6.3 Directions for future research 90 Chapter 7: References 96 Appendices 164 iv Declaration of originality This thesis contains no material which has been accepted for a degree or diploma by the University or any other institution, except by way of background information and duly acknowledged in the thesis, and to the best of my knowledge and belief no material previously published or written by another person except where due acknowledgement is made in the text of the thesis, nor does the thesis contain any material that infringes copyright. Emmanuelle Bostock ................. ............................2018 Authority of Access This thesis may be made available for loan and limited copying and communication in accordance with the Copyright Act 1968. Emmanuelle Bostock .............................. ...........2018 Statement regarding published work contained in thesis The publishers of the papers comprising Chapters 2 to 4 hold the copyright for that content and access to the material should be sought from the respective journals (Journal of Affective Disorders and Frontiers in Psychiatry). The remaining non published content of the thesis may be made available for loan and limited copying and communication in accordance with the Copyright Act 1968. Emmanuelle Bostock ............. ..................................2018 v Copyright permission to reproduce published material: Chapters 2-4 Journal of Affective Disorders (chapter 2): Dear Emmanuelle, Your request to reproduce your article published originally in JAD as part of your PhD thesis has been forwarded to me by Prof. Brambilla. As the published of JAD, I confirm the permission is granted. Kind regards, Agnieszka Agnieszka Freda Publisher | Psychiatry Elsevier Health & Medical Sciences | STM Journals Radarweg 29, 1043 NX Amsterdam, The Netherlands T +31 61 2252 117 [email protected] https://twitter.com/els_psychiatry https://www.facebook.com/elsevierpsychiatry/ Frontiers in Psychiatry (chapter 3, 4 & 5): Dear Dr Bostock, Thank you for your email (below my signature). I would like to confirm that under the Frontiers Terms and Conditions, authors retain the copyright to their work. All Frontiers articles are Open Access and distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits the re-use, distribution and reproduction of material from published articles, provided the original authors and source are credited. Please keep in mind that if anything in the paper, such as a figure, was already under copyright restriction from any other third-party, then you would have to seek permission to reuse the item. I hope I have addressed your question. Please let me know if you have any other questions or concerns. Best regards, Jacques Anken, PhD. Review Operations Assistant vi Acknowledgements I wish to thank with the upmost gratitude Professor Kenneth Kirkby whose patience, expertise and mentorship gave me the confidence to pursue this avenue of research. I am infinitely grateful to Dr Michael Garry and Professor Bruce Taylor who have also assisted me in my PhD journey. Their guidance, expertise and support have been invaluable. I also thank Dr Jason Hawrelak for his thought-provoking course that I undertook concurrently and his knowledge as a co-author for my final paper. I would also thank my parents, Christiane and William who have always been there beside me and shown great interest in my work, also my siblings and friends for their support and love. I acknowledge with gratitude the financial support of the Goddard Sapin-Jaloustre trust and the team at the Institut National de la Santé et de la Recherche Médicale, Montpellier France. vii Statement of Co-Authorship (for inclusion in the thesis) The following people and institutions contributed to the publication of work undertaken as part of this thesis: Name and School = Miss E C Bostock, School of Psychology (candidate) Name and institution = Professor Kenneth Kirkby, University of Tasmania (author 1) Name and institution = Dr Michael Garry, University of Tasmania (author 2) Name and institution = Professor Bruce Taylor, Menzies Research Institute (author 3) Name and institution = Dr Jason Hawrelak, University of Tasmania (author 4) <The candidate must, for each paper, list all authors and provide details of their role in the published work. Where applicable, also provide a percentage estimate of the contribution made by each author. > Author details and their roles: Paper 1, Bostock, E. C. S., Kirkby, K., Garry, M. I. & Taylor, B. V. M. (2015). Comparison of precipitating factors for mania and partial seizures: Indicative of shared pathophysiology? Journal of Affective Disorders, 183, 57-67. doi: 10.1016/j.jad.2015.04.057 Located in chapter 2 Candidate was the primary author, conducted and collated the research. Author 1 contributed to the formalisation and development of the idea through weekly supervision and mentorship. Authors 1, 2 and 3 assisted with refinement and presentation of the publication. Author percent contributions: EB 90%, KK 5%, MG 2.5%, BT 2.5% Paper 2, Bostock, E. C. S., Kirkby, K., Garry, M. I. & Taylor, B. V. M. (2017). Systematic review of cognitive function in euthymic bipolar disorder and pre-surgical temporal lobe epilepsy. Front. Psychiatry, doi: 10.3389/fpsyt.2017.00133 Located in chapter 3 Candidate was the primary author, conducted and collated the research. Author 1 contributed to the formalisation and development of the idea through weekly supervision and mentorship. Authors 1, 2 and 3 assisted with refinement and presentation Author percent contributions: EB 90%, KK 5%, MG 2.5%, BT 2.5% Paper 3, Bostock, E. C. S., Kirkby, K., & Taylor, B. V. M. (2017). The current status of the ketogenic diet in Psychiatry. Front Psychiatry, 8: 43. doi 10.3389/fpsyt.2017.00043 Located chapter 4. Candidate was the primary author, conducted and collated the research. Author 1 contributed to the formalisation and development of the idea through weekly supervision and mentorship. Authors 1 and 3 assisted with refinement and presentation Author percent contributions: EB 90%, KK 5%, MG 2.5%, BT 2.5% Page 1 viii Paper 4, Submitted: Bostock, E. C. S., Kirkby, K., Garry, M. I., Taylor, B. V. M. Hawrelak, J. A. (2018). Mania associated with herbal medicines, other than cannabis: a systematic review and quality assessment of case reports. Located chapter 5. Candidate was the primary author, conducted and collated the research. Author 1 contributed to the formalisation and development of the idea through weekly supervision and mentorship. Authors 1, 2, 3 and 4 assisted with refinement and presentation. Author 4 also assisted with the search strategy. Author percent contributions: EB 85%, KK 5%, JH 5%, MG 2.5%, BT 2.5% We the undersigned agree with the above stated “proportion
Load more

Recommended publications
  • Dextromethorphan Attenuates Sensorineural Hearing Loss in an Animal Model and Population-Based Cohort Study
    International Journal of Environmental Research and Public Health Article Dextromethorphan Attenuates Sensorineural Hearing Loss in an Animal Model and Population-Based Cohort Study Hsin-Chien Chen 1,* , Chih-Hung Wang 1,2 , Wu-Chien Chien 3,4 , Chi-Hsiang Chung 3,4, Cheng-Ping Shih 1, Yi-Chun Lin 1,2, I-Hsun Li 5,6, Yuan-Yung Lin 1,2 and Chao-Yin Kuo 1 1 Department of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan; [email protected] (C.-H.W.); [email protected] (C.-P.S.); [email protected] (Y.-C.L.); [email protected] (Y.-Y.L.); [email protected] (C.-Y.K.) 2 Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 114, Taiwan 3 School of Public Health, National Defense Medical Center, Taipei 114, Taiwan; [email protected] (W.-C.C.); [email protected] (C.-H.C.) 4 Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan 5 Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan; [email protected] 6 School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan * Correspondence: [email protected]; Tel.: +886-2-8792-7192; Fax: +886-2-8792-7193 Received: 31 July 2020; Accepted: 28 August 2020; Published: 31 August 2020 Abstract: The effect of dextromethorphan (DXM) use in sensorineural hearing loss (SNHL) has not been fully examined. We conducted an animal model and nationwide retrospective matched-cohort study to explore the association between DXM use and SNHL.
    [Show full text]
  • Author Index (Print)
    PHYSICAL REVIEW B VOLUME 58, NUMBER 10 1 SEPTEMBER 1998-II Cumulative Author Index All authors of papers published so far in the current volume are listed alphabetically with the issue and page numbers following the dash. A more complete index, with the full title listed with each ®rst author's name and subsequent authors cross-referenced, is published in the last issue of the volume. A cumulative author and subject index covering Physical Review A through E, Physical Review Letters, and Reviews of Modern Physics is published annually under separate cover. AaraÄo Reis, F. D. A.Ð͑1͒ 394 Ancilotto, FrancescoÐ͑8͒ 5085 Awaga, KunioÐ͑5͒ 2438 Abarra, E. N.Ð͑9͒ 5672 Anders, S.Ð͑9͒ 5825; ͑10͒ 6639 Awschalom, D. D.Ð͑8͒ R4238 Abbate, M.Ð͑7͒ 3755 Andersen, N. H.Ð͑10͒ 6291 AxnaÈs, J.Ð͑10͒ 6628 Abd-Elmeguid, M. M.Ð͑1͒ 254 Andersen, O. K.Ð͑1͒ 522; ͑2͒ 1025 Ayaz, YuÈkselÐ͑4͒ 2001 Abe, K.Ð͑5͒ 2513 Andersson, M.Ð͑10͒ 6580 Aydinol, M. K.Ð͑6͒ 2975 Abelson, J. R.Ð͑8͒ 4803 Andersson, Per H.Ð͑9͒ 5230 Azevedo, A.Ð͑1͒ 101 Abliz, M.Ð͑9͒ 5205 Ando, K.Ð͑3͒ 1100; ͑4͒ 1912 Aziz, M. J.Ð͑8͒ 4579 Abolfath, M.Ð͑4͒ 2013 Ando, TsuneyaÐ͑3͒ 1485 Aziz, Michael J.Ð͑1͒ 189 Abraha, KamsulÐ͑2͒ 897 Ando, YoichiÐ͑6͒ R2913 Abrahams, ElihuÐ͑2͒ R559 AndraÈ, W.Ð͑10͒ 6346 Baars, T.Ð͑4͒ R1750 Abramo, Maria C.Ð͑5͒ 2372 AndreÂ, G.Ð͑2͒ 847 Baberschke, K.Ð͑9͒ 5611, 5701 Abrikosov, A. A.Ð͑5͒ 2788 Andreev, AntonÐ͑9͒ 5149 Bacherler, Th.Ð͑3͒ 1633 Abrikosov, I. A.Ð͑7͒ 3613 Andrei, N.Ð͑6͒ R2921 Bachlechner, M. E.Ð͑4͒ 1887 Abrosimov, N.
    [Show full text]
  • A Case Study on Addressing Abuse of a Safe and Effective Drug David C
    Spangler et al. Substance Abuse Treatment, Prevention, and Policy (2016) 11:22 DOI 10.1186/s13011-016-0067-0 DEBATE Open Access Dextromethorphan: a case study on addressing abuse of a safe and effective drug David C. Spangler1, Catherine M. Loyd1* and Emily E. Skor1,2 Abstract Background: Dextromethorphan is a safe, effective cough suppressant, available without a prescription in the United States since 1958. Due to a perceived prevalence of abuse of dextromethorphan by teens, in 2007 the Drug Enforcement Administration requested the Food and Drug Administration evaluate whether dextromethorphan should be recommended for scheduling under the Controlled Substances Act. The Food and Drug Administration held an Advisory Committee meeting in 2010 to provide a scientific and medical evaluation of dextromethorphan and its abuse potential. Discussion: To address reports of abuse, particularly by teens in the United States, the Consumer Healthcare Products Association initiated an abuse mitigation plan in 2010 with specific goals related to awareness of the behavior, perception of risk, social disapproval, and access to the products. In identifying abuse interventions, experts acknowledge that substance abuse among teens is a highly complex behavior and indicate that the best course of action is to address prevention by focusing on the factors that impact teen behavior. Conclusion: It is noteworthy that the annual prevalence of over-the-counter cough medicine abuse has sharply decreased since 2010. While a true cause-and-effect relationship cannot be assured, the Consumer Healthcare Products Association and its member companies believe that the increased awareness of the issue since the 2010 Food and Drug Administration Advisory Committee meeting, and the subsequent implementation of a well-delivered and targeted abuse mitigation plan that addressed the levers influencing teen decisions is contributing to the observed reduction in abuse.
    [Show full text]
  • Lithium Stimulates Glutamate "Release" and Inositol 1,4,5
    Proc. Nat!. Acad. Sci. USA Vol. 91, pp. 8358-8362, August 1994 Neurobiology Lithium stimulates glutamate "release" and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices (manic depression/bipolar disorder/primates) JOHN F. DIXON, GEORGYI V. Los, AND LOWELL E. HOKIN* Department of Pharmacology, University of Wisconsin Medical School, 1300 University Avenue, Madison, WI 53706 Communicated by Henry Lardy, May 9, 1994 (received for review February 18, 1994) ABSTRACT Beginning at therapeutic concentrations (1- showed lithium-stimulated increases in Ins(1,4,5)P3 and 1.5 mM), the anti-manic-depressive drug lithium stimulated inositol 1,3,4,5-tetrakisphosphate (2). the release of glutamate, a major excitatory neurotransmitter In the case of rhesus monkey, neither inositol nor an in the brain, in monkey cerebral cortex slices in a time- and agonist was required to demonstrate lithium-stimulated ac- concentration-dependent manner, and this was associated with cumulation of Ins(1,4,5)P3 (3). This suggested that an endog- increased inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] accumu- enous neurotransmitter was involved in the lithium effect. lation. (±)-3-(2-Carboxypiperazin-4-yl)propyl-1-phosphoric We show here that, beginning at therapeutic concentrations, acid (CPP), dizocilpine (MK-801), ketamine, and Mg2+- lithium stimulated the release ofglutamate in rhesus monkey antagonists to the N-methyl-D-aspartate (NMDA) recep- and mouse cerebral cortex slices, and this in turn increased tor/channel complex selectively inhibited lithium-stimulated accumulation of Ins(1,4,5)P3 via activation of the N-methyl- Ins(t,4,5)P3 accumulation.
    [Show full text]
  • The German Surname Atlas Project ± Computer-Based Surname Geography Kathrin Dräger Mirjam Schmuck Germany
    Kathrin Dräger, Mirjam Schmuck, Germany 319 The German Surname Atlas Project ± Computer-Based Surname Geography Kathrin Dräger Mirjam Schmuck Germany Abstract The German Surname Atlas (Deutscher Familiennamenatlas, DFA) project is presented below. The surname maps are based on German fixed network telephone lines (in 2005) with German postal districts as graticules. In our project, we use this data to explore the areal variation in lexical (e.g., Schröder/Schneider µtailor¶) as well as phonological (e.g., Hauser/Häuser/Heuser) and morphological (e.g., patronyms such as Petersen/Peters/Peter) aspects of German surnames. German surnames emerged quite early on and preserve linguistic material which is up to 900 years old. This enables us to draw conclusions from today¶s areal distribution, e.g., on medieval dialect variation, writing traditions and cultural life. Containing not only German surnames but also foreign names, our huge database opens up possibilities for new areas of research, such as surnames and migration. Due to the close contact with Slavonic languages (original Slavonic population in the east, former eastern territories, migration), original Slavonic surnames make up the largest part of the foreign names (e.g., ±ski 16,386 types/293,474 tokens). Various adaptations from Slavonic to German and vice versa occurred. These included graphical (e.g., Dobschinski < Dobrzynski) as well as morphological adaptations (hybrid forms: e.g., Fuhrmanski) and folk-etymological reinterpretations (e.g., Rehsack < Czech Reåak). *** 1. The German surname system In the German speech area, people generally started to use an addition to their given names from the eleventh to the sixteenth century, some even later.
    [Show full text]
  • Janssen Research & Development, LLC Advisory Committee Briefing
    Janssen Research & Development, LLC Advisory Committee Briefing Document Esketamine Nasal Spray for Patients with Treatment-resistant Depression JNJ-54135419 (esketamine) Status: Approved Date: 16 January 2019 Prepared by: Janssen Research & Development, LLC EDMS number: EDMS-ERI-171521650, 1.0 ADVISORY COMMITTEE BRIEFING MATERIALS: AVAILABLE FOR PUBLIC RELEASE 1 Status: Approved, Date: 16 January 2019 JNJ-54135419 (esketamine) Treatment-resistant Depression Advisory Committee Briefing Document GUIDE FOR REVIEWERS This briefing document provides 3 levels of review with increasing levels of detail: The Executive Overview (Section 1, starting on page 11) provides a narrative summarizing the disease, need for novel treatments, key development program characteristics for esketamine nasal spray, study results, and conclusions. References are made to the respective supporting sections in the core document. The core document (Section 2 to Section 11, starting on page 30) includes detailed summaries and discussion in support of the Executive Overview. The appendices (starting on page 180) provide additional or more detailed information to complement brief descriptions provided in sections of the core document (e.g., demographic and baseline characteristics of the study populations, additional efficacy analyses in the Phase 3 studies, statistical methods). These appendices are referenced in the core document when relevant. This review structure allows review at varying levels of detail; however, reviewers who read at multiple levels will necessarily
    [Show full text]
  • Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss
    Supplemental Material can be found at: /content/suppl/2020/12/18/73.1.202.DC1.html 1521-0081/73/1/202–277$35.00 https://doi.org/10.1124/pharmrev.120.000056 PHARMACOLOGICAL REVIEWS Pharmacol Rev 73:202–277, January 2021 Copyright © 2020 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. ASSOCIATE EDITOR: MICHAEL NADER Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss Antonio Inserra, Danilo De Gregorio, and Gabriella Gobbi Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, Quebec, Canada Abstract ...................................................................................205 Significance Statement. ..................................................................205 I. Introduction . ..............................................................................205 A. Review Outline ........................................................................205 B. Psychiatric Disorders and the Need for Novel Pharmacotherapies .......................206 C. Psychedelic Compounds as Novel Therapeutics in Psychiatry: Overview and Comparison with Current Available Treatments . .....................................206 D. Classical or Serotonergic Psychedelics versus Nonclassical Psychedelics: Definition ......208 Downloaded from E. Dissociative Anesthetics................................................................209 F. Empathogens-Entactogens . ............................................................209
    [Show full text]
  • Development of Allosteric Modulators of Gpcrs for Treatment of CNS Disorders Hilary Highfield Nickols A, P
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Neurobiology of Disease 61 (2014) 55–71 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Review Development of allosteric modulators of GPCRs for treatment of CNS disorders Hilary Highfield Nickols a, P. Jeffrey Conn b,⁎ a Division of Neuropathology, Department of Pathology, Microbiology and Immunology, Vanderbilt University, USA b Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA article info abstract Article history: The discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a promising new strategy Received 25 July 2013 with potential for developing novel treatments for a variety of central nervous system (CNS) disorders. Tradition- Revised 13 September 2013 al drug discovery efforts targeting GPCRs have focused on developing ligands for orthosteric sites which bind en- Accepted 17 September 2013 dogenous ligands. Allosteric modulators target a site separate from the orthosteric site to modulate receptor Available online 27 September 2013 function. These allosteric agents can either potentiate (positive allosteric modulator, PAM) or inhibit (negative allosteric modulator, NAM) the receptor response and often provide much greater subtype selectivity than Keywords: Allosteric modulator orthosteric ligands for the same receptors. Experimental evidence has revealed more nuanced pharmacological CNS modes of action of allosteric modulators, with some PAMs showing allosteric agonism in combination with pos- Drug discovery itive allosteric modulation in response to endogenous ligand (ago-potentiators) as well as “bitopic” ligands that GPCR interact with both the allosteric and orthosteric sites. Drugs targeting the allosteric site allow for increased drug Metabotropic glutamate receptor selectivity and potentially decreased adverse side effects.
    [Show full text]
  • The Effects of Ketamine on Dopaminergic Function: Meta-Analysis and Review of the Implications for Neuropsychiatric Disorders
    OPEN Molecular Psychiatry (2018) 23, 59–69 www.nature.com/mp REVIEW The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders M Kokkinou1,2, AH Ashok1,2,3 and OD Howes1,2,3 Ketamine is a non-competitive antagonist at the N-methyl-D-aspartate receptor. It has recently been found to have antidepressant effects and is a drug of abuse, suggesting it may have dopaminergic effects. To examine the effect of ketamine on the dopamine systems, we carried out a systematic review and meta-analysis of dopamine measures in the rodent, human and primate brain following acute and chronic ketamine administration relative to a drug-free baseline or control condition. Systematic search of PubMed and PsychInfo electronic databases yielded 40 original peer-reviewed studies. There were sufficient rodent studies of the acute effects of ketamine at sub-anaesthetic doses for meta-analysis. Acute ketamine administration in rodents is associated with significantly increased dopamine levels in the cortex (Hedge’s g = 1.33, Po0.01), striatum (Hedge’s g = 0.57, Po0.05) and the nucleus accumbens (Hedge’s g = 1.30, Po0.05) compared to control conditions, and 62–180% increases in dopamine neuron population activity. Sub-analysis indicated elevations were more marked in in vivo (g = 1.93) than ex vivo (g = 0.50) studies. There were not enough studies for meta-analysis in other brain regions studied (hippocampus, ventral pallidum and cerebellum), or of the effects of chronic ketamine administration, although consistent increases in cortical dopamine levels (from 88 to 180%) were reported in the latter studies.
    [Show full text]
  • Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Secretary: Rachel Fowler 3Rd Floor Seacole Building 2
    ACMD Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Secretary: Rachel Fowler 3rd Floor Seacole Building 2. Marsham Street London SW1P 4DF 020 7035 0454 Email: [email protected] Rt Hon. Theresa May MP Home Office 2 Marsham Street London SW1P 4DF 18th October 2012 Dear Home Secretary, In March 2012 the ACMD advised that methoxetamine be subject to a temporary class drug order. Methoxetamine was marketed as a legal alternative to ketamine until a temporary class drug order was implemented in April 2012. As is now required, the ACMD has followed its initial assessment with a consideration of methoxetamine in the context of the Misuse of Drugs Act 1971; I enclose the report with this letter. The chemical structure of methoxetamine bears a close resemblance to that of both ketamine and phencyclidine (PCP, „Angel Dust‟, a class A drug), which both produce well- documented and serious adverse effects following both acute and chronic usage. Users report that the effects of methoxetamine are similar to those of ketamine, however, some users report that the effects are of longer duration.The harmful effects reported include severe dissociation, cardiovascular symptoms, paranoid thoughts and unpleasant hallucinations. The first analytically confirmed series reported by Guy‟s and St Thomas‟ NHS Foundation Trust, London in 2011, was of three individuals who presented having self-reported use of methoxetamine. All three presented with a ketamine-like dissociative state, but also had significant stimulant effects with agitation and cardiovascular effects including tachycardia and hypertension. Toxicological screening of serum samples confirmed methoxetamine use in two of the cases.
    [Show full text]
  • Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
    1521-0103/359/1/159–170$25.00 http://dx.doi.org/10.1124/jpet.116.235838 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 359:159–170, October 2016 U.S. Government work not protected by U.S. copyright Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters Adem Can,1 Panos Zanos,1 Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang, and Todd D. Gould Department of Psychiatry (A.C., P.Z., J.F.C., D.O.F., T.D.G.), Department of Pharmacology (D.O.F, T.D.G), and Department of Anatomy and Neurobiology (J.F.C, T.D.G), University of Maryland School of Medicine, Baltimore, Maryland; Department of Psychology, Notre Dame of Maryland University, Baltimore, Maryland (A.C.); Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Maryland (R.M., K.S.S.D., I.W.W.); National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina Chapel Hill Medical School, Chapel Hill, North Carolina (H.J.K., X.-P.H.); and Mitchell Woods Pharmaceuticals, Shelton, Connecticut (I.W.W.) Received June 14, 2016; accepted July 27, 2016 ABSTRACT Following administration at subanesthetic doses, (R,S)-ketamine mesolimbic DA release and decay using fast-scan cyclic (ketamine) induces rapid and robust relief from symptoms of voltammetry following acute administration of subanesthetic depression in treatment-refractory depressed patients. Previous doses of ketamine (2, 10, and 50 mg/kg, i.p.).
    [Show full text]
  • PETITION List 04-30-13 Columns
    PETITION TO FREE LYNNE STEWART: SAVE HER LIFE – RELEASE HER NOW! • 1 Signatories as of 04/30/13 Arian A., Brooklyn, New York Ilana Abramovitch, Brooklyn, New York Clare A., Redondo Beach, California Alexis Abrams, Los Angeles, California K. A., Mexico Danielle Abrams, Ann Arbor, Michigan Kassim S. A., Malaysia Danielle Abrams, Brooklyn, New York N. A., Philadelphia, Pennsylvania Geoffrey Abrams, New York, New York Tristan A., Fort Mill, South Carolina Nicholas Abramson, Shady, New York Cory a'Ghobhainn, Los Angeles, California Elizabeth Abrantes, Cambridge, Canada Tajwar Aamir, Lawrenceville, New Jersey Alberto P. Abreus, Cliffside Park, New Jersey Rashid Abass, Malabar, Port Elizabeth, South Salma Abu Ayyash, Boston, Massachusetts Africa Cheryle Abul-Husn, Crown Point, Indiana Jamshed Abbas, Vancouver, Canada Fadia Abulhajj, Minneapolis, Minnesota Mansoor Abbas, Southington, Connecticut Janne Abullarade, Seattle, Washington Andrew Abbey, Pleasanton, California Maher Abunamous, North Bergen, New Jersey Andrea Abbott, Oceanport, New Jersey Meredith Aby, Minneapolis, Minnesota Laura Abbott, Woodstock, New York Alexander Ace, New York, New York Asad Abdallah, Houston, Texas Leela Acharya, Toronto, Canada Samiha Abdeldjebar, Corsham, United Kingdom Dennis Acker, Los Angeles, California Mohammad Abdelhadi, North Bergen, New Jersey Judith Ackerman, New York, New York Abdifatah Abdi, Minneapolis, Minnesota Marilyn Ackerman, Brooklyn, New York Hamdiya Fatimah Abdul-Aleem, Charlotte, North Eddie Acosta, Silver Spring, Maryland Carolina Maria Acosta,
    [Show full text]